[go: up one dir, main page]

CH566784A5 - - Google Patents

Info

Publication number
CH566784A5
CH566784A5 CH633872A CH633872A CH566784A5 CH 566784 A5 CH566784 A5 CH 566784A5 CH 633872 A CH633872 A CH 633872A CH 633872 A CH633872 A CH 633872A CH 566784 A5 CH566784 A5 CH 566784A5
Authority
CH
Switzerland
Application number
CH633872A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH566784A5 publication Critical patent/CH566784A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH633872A 1971-04-30 1972-04-28 CH566784A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
CH566784A5 true CH566784A5 (xx) 1975-09-30

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
CH633872A CH566784A5 (xx) 1971-04-30 1972-04-28

Country Status (23)

Country Link
US (1) US3758683A (xx)
JP (1) JPS5735185B1 (xx)
BE (1) BE782651A (xx)
CA (1) CA976085A (xx)
CH (1) CH566784A5 (xx)
CS (1) CS209458B2 (xx)
DD (1) DD100708A5 (xx)
DE (1) DE2219635C3 (xx)
DK (1) DK131760C (xx)
ES (1) ES402176A1 (xx)
FI (1) FI49773C (xx)
FR (1) FR2134658B1 (xx)
GB (1) GB1385086A (xx)
HU (1) HU166989B (xx)
IL (1) IL39181A (xx)
NL (1) NL178258C (xx)
NO (1) NO137178C (xx)
PL (1) PL86966B1 (xx)
RO (1) RO64387A (xx)
SE (1) SE378066B (xx)
SU (1) SU508162A3 (xx)
YU (1) YU36155B (xx)
ZA (1) ZA722243B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
CA1339416C (en) * 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
KR101820024B1 (ko) 2008-10-17 2018-01-18 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 glp-1 효능제의 병용물
LT2498801T (lt) 2009-11-13 2018-05-10 Sanofi-Aventis Deutschland Gmbh Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
PL3417871T3 (pl) 2009-11-13 2021-06-14 Sanofi-Aventis Deutschland Gmbh Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN118903386A (zh) 2017-08-24 2024-11-08 诺和诺德股份有限公司 Glp-1组合物及其用途
BR112022013746A2 (pt) 2020-02-18 2022-10-11 Novo Nordisk As Formulação aquosa de cagrilintida, formulação aquosa de semaglutida, dispositivo médico, e, combinação de dose fixa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
DE2219635C3 (de) 1981-10-15
DK131760B (da) 1975-09-01
FR2134658A1 (xx) 1972-12-08
PL86966B1 (xx) 1976-06-30
GB1385086A (en) 1975-02-26
CS209458B2 (en) 1981-12-31
JPS5735185B1 (xx) 1982-07-27
HU166989B (xx) 1975-07-28
BE782651A (fr) 1972-10-26
DE2219635A1 (de) 1972-11-09
NL178258B (nl) 1985-09-16
DK131760C (da) 1976-02-02
ZA722243B (en) 1973-11-28
IL39181A (en) 1974-09-10
YU36155B (en) 1982-02-25
FI49773C (fi) 1975-10-10
FI49773B (xx) 1975-06-30
SE378066B (xx) 1975-08-18
ES402176A1 (es) 1975-03-01
NO137178B (no) 1977-10-10
US3758683A (en) 1973-09-11
NL178258C (nl) 1986-02-17
NO137178C (no) 1978-01-18
RO64387A (fr) 1979-07-15
SU508162A3 (ru) 1976-03-25
YU114272A (en) 1981-06-30
NL7205865A (xx) 1972-11-01
IL39181A0 (en) 1972-06-28
DD100708A5 (xx) 1973-10-05
DE2219635B2 (de) 1980-11-27
FR2134658B1 (xx) 1975-10-17
CA976085A (en) 1975-10-14

Similar Documents

Publication Publication Date Title
FI49773B (xx)
ATA136472A (xx)
AU2691671A (xx)
AU2684071A (xx)
AU2485671A (xx)
AU2742671A (xx)
AU2894671A (xx)
AU2740271A (xx)
AU2724971A (xx)
AU2875571A (xx)
AU2473671A (xx)
AU2854371A (xx)
AU2684171A (xx)
AU2837671A (xx)
AU2455871A (xx)
AU2880771A (xx)
AU2415871A (xx)
AU2907471A (xx)
AU2706571A (xx)
AU2456871A (xx)
AU2399971A (xx)
AU2726271A (xx)
AU1109576A (xx)
AR199640Q (xx)
AR202997Q (xx)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased